DHS241220P98000
- 0.00
- 0.000.00%
Wisdomtree Trust High Dividend Fund Newsroom
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
A retrospective on the OpenAI series of conferences: From tools to AGI, the evolution of OpenAI in 12 days.
In the first four days, the official version of o1, Sora, and Canvas were launched with great impact; after a few days of 'silence' in between, the last day directly revealed a game-changer—GPT-o3, which broke the skepticism surrounding the bottleneck in AI development.
Musk causes a commotion at Capitol Hill, is a "Trump 2.0" prototype emerging?
Analysis suggests that Musk's recent act of detonating a political nuclear bomb may be a rehearsal for the Trump 2.0 era of Musk's action model, intended to exert pressure on Congress. However, some also say that the consensus at Mar-a-Lago is that Musk has proven to be an effective Weapon to pressure Congress and a scapegoat for any backlash.
Deal Dispatch: Honeywell, Textron And Soho House Are Making M&A Moves
Key Deals for the Week: Accenture, Berkshire Hills Bancorp, NXP Semiconductors and More
As Quantum Computing Stocks Soar, Wall Street Analysts Take Bullish Stance
U.S. stocks closed | "Triple Witching Day" saw a major rebound in U.S. stocks! All three major Indexes rose by over 1%; the AI application Concept exploded, with Palantir rising over 8%.
Ed Yardeni, the most accurate Analyst on Wall Street and president of Yardeni Research, is optimistic about the U.S. stock market, predicting that the S&P 500 will reach 7,000 points next year and 8,000 points the year after.
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Defensive Oil Stocks To Watch In 2025 Amid $70 Brent Forecast: JP Morgan
Merck Downgraded by BMO Over Keytruda Concerns
RxSight Cut to Hold at Stifel on Competition Concerns
Dividend Roundup: Mastercard, Broadcom, Southwest Airlines, Waste Management, and More
Merck Disclosed Closing Of Exclusive Global License Agreement For LM-299, A Novel Investigational PD-1/VEGF Bispecific Antibody From LaNova Medicine; Company To Record Pre-tax Charge Relating To Upfront Payment Of $588M, Or $0.18 Per Share, In Q4 2024...
BMO Capital Downgrades Merck & Co to Market Perform, Lowers Price Target to $105
Merck & Co Analyst Ratings
If a "perfect storm" hits, oil prices may fall below 50 dollars next year.
Oil market bulls are now most afraid of an economic recession.....
Noon Crude Oil Analysis: Will crude oil prices be pressured or rebound against the backdrop of a strengthening dollar?
Due to market expectations that a stronger US dollar may suppress oil demand, the Intercontinental Exchange (ICE) Brent Crude Oil Product Futures prices fell slightly in early morning trading in Asia.
Lumen Wireline Assets May Be Worth $7B-$10B in a Sale - Analyst
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Spotlight on Chevron: Analyzing the Surge in Options Activity